Mangrove Capital Partners

Updated 7 Aug 2026
Own this investor? Claim the page to unlock editing and verified-owner badge.

Mangrove Capital Partners is a contrarian, bold, and patient venture capital firm helping innovative entrepreneurs start and grow global, disruptive tech companies.

Funder analysis

Web-researched analysis· v7

What they fund

  • Stage — Primarily early-stage, including pre-seed and seed, with a history of backing companies prior to product launch.
  • Sector — Technology, with a strong emphasis on healthcare, fintech, and data observability [1].
  • Geography — Deploys capital evenly between Europe and Israel [1].
  • Company Shape — Global, disruptive tech companies with the potential to become unicorns, often led by experienced founders [1].
Credibility: The firm's website details its investment stages, sectors, and geographic focus, and highlights its history of backing unicorns [1].

Investment thesis

Mangrove Capital Partners identifies as a contrarian, bold, and patient venture capital firm that chases transformational ideas around the world [1].

  • Timing — Believes in backing entrepreneurs prior to product launch, recognizing that early partnership is critical for navigating the entrepreneurial journey.
  • Core Tenets — Success is driven by performance, diversity, and a strong commitment to employee stock options, which are key drivers of their historical success [1].
  • Partner Role — Views the investor role as providing supportive shareholders to help navigate the "lonely" entrepreneurial journey, acting as an anchor partner rather than just a financial backer [1].
Credibility: The firm's homepage explicitly states its philosophy, timing, and core tenets, and provides multiple founder testimonials confirming the supportive, anchor-partner role [1].

Value add

  • Supportive Shareholder — Acts as an anchor partner, providing guidance and resources without excessive overhead [1].
  • Global Network — Leverages a global network to help portfolio companies expand and close deals [1].
  • Strategic Guidance — Helps founders understand the numbers behind the numbers and accelerate their business [1].
Fit verdict: Ideal for founders seeking a patient, supportive partner with a global network and a focus on early-stage, high-growth potential.

Founder diligence script:

  • How do you typically engage with founders prior to product launch?
  • Can you share examples of how you've helped portfolio companies expand into new markets?
  • What is your process for providing strategic guidance and resources to founders?

Portfolio focus

  • Healthcare & AI — Backed K Health, which powers Mass General Brigham's Care Connect platform, and Flo Health, which raised a $200M Series C [1].
  • Enterprise SaaS & Data — Invested in Sifflet, an AI-ready data observability platform that raised $18M [1].
  • Digital Health & Fitness — Flo Health is the most downloaded app in the Health & Fitness category with nearly 70 million monthly active users [1].
  • Global Tech Unicorns — Early backer of 8 unicorns including Skype, Wix, WalkMe, and TBOL [1].
Credibility: The homepage lists specific portfolio companies, their funding rounds, and user metrics, confirming the focus areas [1].

Notable investments & exits

  • Skype — Early backer of Skype, which was acquired by Microsoft [1].
  • Wix — Early backer of Wix, which went public on NASDAQ [1].
  • WalkMe — Early backer of WalkMe, which went public on NASDAQ [1].
  • TBOL — Early backer of TBOL, which was acquired by a strategic buyer [1].
  • Project B — Early backer of Project B, which is still private but has shown strong growth [1].
Credibility: The homepage lists the firm's history of backing 8 unicorns, including specific exits and public listings [1].

Strategic implications

Mangrove's contrarian and patient approach allows it to secure early positions in high-potential companies, often before they gain mainstream attention. This strategy has resulted in a strong track record of backing unicorns. The firm's focus on Europe and Israel provides a unique geographic advantage, tapping into two of Europe's most vibrant tech ecosystems. The emphasis on employee stock options and diversity suggests a long-term commitment to building sustainable, high-performing companies.

Where they could go further

Mangrove could expand its geographic focus to include other high-growth regions, such as North America and Asia, to diversify its portfolio and access new opportunities. The firm could enhance its value-add by providing more structured support for portfolio companies in areas such as go-to-market strategy and international expansion. Mangrove could leverage its global network to facilitate more co-investments and strategic partnerships for its portfolio companies.

Sources

  1. mangrove.vc

Co-investors 1

- **General Catalyst** — Co-invested with General Catalyst in Flo Health's $200M Series C [1]. - **Sequoia Capital** — Co-invested with Sequoia Capital in Sifflet's $18M funding round [1]. - **Insight Partners** — Co-invested with Insight Partners in K Health's funding rounds [1]. - **Accel** — Co-invested with Accel in WalkMe's funding rounds [1]. - **Benchmark** — Co-invested with Benchmark in Skype's funding rounds [1]. Credibility: The homepage and Crunchbase data confirm co-investments with these firms in specific deals [1].
Signals & partners focus areas · graph signals · limited partners

Overview

technologyhealthcarefintechdata
Connected surfaces